Jeffrey Del Carmen
Net Worth

Last updated:

What is Jeffrey Del Carmen net worth?

The estimated net worth of Mr. Jeffrey Del Carmen is at least $4,227,421 as of 9 Dec 2024. He owns shares worth $249,359 as insider, has earned $1,946,222 from insider trading and has received compensation worth at least $2,031,840 in Catalyst Pharmaceuticals, Inc..

What is the salary of Jeffrey Del Carmen?

Mr. Jeffrey Del Carmen salary is $507,960 per year as Chief Commercial Officer in Catalyst Pharmaceuticals, Inc..

How old is Jeffrey Del Carmen?

Mr. Jeffrey Del Carmen is 54 years old, born in 1971.

What stocks does Jeffrey Del Carmen currently own?

As insider, Mr. Jeffrey Del Carmen owns shares in one company:

Company Title Shares Price per share Total value
Catalyst Pharmaceuticals, Inc. (CPRX) Chief Commercial Officer 12,369 $20.16 $249,359

What does Catalyst Pharmaceuticals, Inc. do?

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

CPRX logo
CPRX
Catalyst Pharmaceuticals, Inc.
$20.16

Jeffrey Del Carmen insider trading

Catalyst Pharmaceuticals, Inc.

Mr. Jeffrey Del Carmen has made 5 insider trades between 2021-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 120,000 units of CPRX stock on 11 Nov 2022. As of 9 Dec 2024 he still owns at least 12,369 units of CPRX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 8,039 N/A N/A
Option
Common stock, par value $0.001 per share 8,039 N/A N/A
Option
Common stock, par value $0.001 per share 30,000 $2.86 $85,800
Option
Options to purchase common stock 30,000 $2.86 $85,800
Sale
Common stock, par value $0.001 per share 36,058 $18.43 $664,549
Sale
Common stock, par value $0.001 per share 7,541 $16.07 $121,184
Option
Common stock, par value $0.001 per share 10,667 N/A N/A
Option
Restricted Stock Units 10,667 N/A N/A
Option
Restricted Stock Units 8,666 N/A N/A
Option
Common stock, par value $0.001 per share 8,666 N/A N/A
Option
Common stock, par value $0.001 per share 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Option
Common stock, par value $0.001 per share 20,983 $2.24 $47,002
Option
Common stock, par value $0.001 per share 19,017 $4.21 $80,062
Sale
Common stock, par value $0.001 per share 40,000 $16.7 $667,800
Option
Options to purchase common stock 19,017 $4.21 $80,062
Option
Options to purchase common stock 20,983 $2.24 $47,002
Option
Common stock, par value $0.001 per share 10,666 N/A N/A
Option
Restricted Stock Units 10,666 N/A N/A
Option
Options to purchase common stock 120,000 $2.86 $343,200
Option
Common stock, par value $0.001 per share 19,017 $2.24 $42,598
Option
Common stock, par value $0.001 per share 120,000 $2.86 $343,200
Option
Options to purchase common stock 19,017 $2.24 $42,598
Sale
Common stock, par value $0.001 per share 19,017 $15.46 $294,022
Sale
Common stock, par value $0.001 per share 14,140 $14.05 $198,667
Option
Common stock, par value $0.001 per share 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A
Option
Common stock, par value $0.001 per share 10,000 N/A N/A
Option
Restricted Stock Units 10,000 N/A N/A

Catalyst Pharmaceuticals key executives

Catalyst Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: